{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:37:35Z","timestamp":1793515055453,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00108-020-00890-1","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T15:03:20Z","timestamp":1603897400000},"page":"1249-1263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gastro\u00f6sophageale Refluxkrankheit \u2013 Update 2021","Gastro-oesophageal reflux disease\u2014update 2021"],"prefix":"10.1007","volume":"61","author":[{"given":"J.","family":"Labenz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-P.","family":"Borkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Labenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"key":"890_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11377-016-0045-0","volume":"11","author":"J Labenz","year":"2016","unstructured":"Labenz\u00a0J, Labenz\u00a0C (2016) Pr\u00e4valenz und nat\u00fcrlicher Verlauf der gastro\u00f6sophagealen Refluxkrankheit. Gastroenterologe 11:102\u2013109","journal-title":"Gastroenterologe"},{"key":"890_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.gastro.2017.07.045","volume":"154","author":"JE Richter","year":"2018","unstructured":"Richter\u00a0JE, Rubinstein\u00a0JH (2018) Presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology 154:267\u2013276","journal-title":"Gastroenterology"},{"key":"890_CR3","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1055\/s-0034-1385202","volume":"52","author":"H Koop","year":"2014","unstructured":"Koop\u00a0H, Fuchs\u00a0KH, Labenz\u00a0J, Lynen Jansen\u00a0P, Messmann\u00a0H, Miehlke\u00a0S et al (2014) S2k-Guideline: Gastroesophageal reflux disease guided by the German Society of Gastroenterology. Z\u00a0Gastroenterol 52:1299\u20131346","journal-title":"Z Gastroenterol"},{"key":"890_CR4","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil\u00a0N, van Zanten\u00a0SV, Kahrilas\u00a0P, Dent\u00a0J, Jones\u00a0R, Global Consensus Group (2006) The Montreal definition and classification of gastroesophageal reflux disease: a\u00a0global evidence-based consensus. Am J Gastroenterol 101:1900\u20131920","journal-title":"Am J Gastroenterol"},{"key":"890_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00108-016-0152-5","volume":"57","author":"J Labenz","year":"2016","unstructured":"Labenz\u00a0J (2016) Barrett-\u00d6sophagus. Internist 57:1079\u20131092","journal-title":"Internist"},{"key":"890_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1053\/j.gastro.2017.07.040","volume":"154","author":"MF Vaezi","year":"2018","unstructured":"Vaezi\u00a0MF, Sifrim\u00a0D (2018) Assessing old and new diagnostic tests for gastroesophageal reflux disease. Gastroenterology 154:289\u2013301","journal-title":"Gastroenterology"},{"key":"890_CR7","doi-asserted-by":"crossref","unstructured":"Tack J, Pandolfino JE (1018) Pathophysiology of gastroesophageal reflux disease. Gastroenterology 154:277\u2013288","DOI":"10.1053\/j.gastro.2017.09.047"},{"key":"890_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00108-016-0164-1","volume":"58","author":"J Labenz","year":"2017","unstructured":"Labenz\u00a0J, Labenz\u00a0C (2017) Gastroenterological diseases as triggers of chest pain. Internist 58:29\u201338","journal-title":"Internist"},{"key":"890_CR9","doi-asserted-by":"publisher","first-page":"E311","DOI":"10.1055\/s-0042-101021","volume":"4","author":"I Hansdotter","year":"2016","unstructured":"Hansdotter\u00a0I, Bj\u00f6r\u00a0O, Andreasson\u00a0A, Agreus\u00a0L, Hellstr\u00f6m\u00a0P, Forsberg\u00a0A et al (2016) Hill classification is superior to the axial length of a\u00a0hiatal hernia for assessment of the mechanical anti-reflux barrier at the gastroesophageal junction. Endosc Inter Open 4:E311\u2013E317","journal-title":"Endosc Inter Open"},{"key":"890_CR10","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/gutjnl-2013-306393","volume":"63","author":"G Boeckxstaens","year":"2014","unstructured":"Boeckxstaens\u00a0G, El-Serag\u00a0HB, Smout\u00a0AJ, Kahrilas\u00a0PJ (2014) Symptomatic reflux disease: the present, the past and the future. Gut 63:1185\u20131193","journal-title":"Gut"},{"key":"890_CR11","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/gutjnl-2017-314722","volume":"67","author":"CP Gyawali","year":"2018","unstructured":"Gyawali\u00a0CP, Kahrilas\u00a0PJ, Savarino\u00a0E, Zerbib\u00a0F, Mion\u00a0F, Smout\u00a0AJPM et\u00a0al (2018) Modern diagnosis of GERD: the Lyon consensus. Gut 67:1351\u20131362","journal-title":"Gut"},{"key":"890_CR12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.cgh.2019.07.015","volume":"18","author":"DA Katzka","year":"2020","unstructured":"Katzka\u00a0DA, Pandolfino\u00a0JE, Kahrilas\u00a0PJ (2020) Phenotypes of gastroesophageal reflux disease: where Rome, Lyon, and Montreal meet. Clin Gastroenterol Hepatol 18:767\u2013776","journal-title":"Clin Gastroenterol Hepatol"},{"key":"890_CR13","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.cgh.2018.02.001","volume":"16","author":"MF Vaezi","year":"2018","unstructured":"Vaezi\u00a0MF, Katzka\u00a0D, Zerbib\u00a0F (2018) Extraesophageal symptoms and diseases attributed to GERD: where is the pendulum swinging now? Clin Gastroenterol Hepatol 16:1018\u20131029","journal-title":"Clin Gastroenterol Hepatol"},{"key":"890_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(18)31388-6","volume":"392","author":"JAZ Jankowski","year":"2018","unstructured":"Jankowski\u00a0JAZ, de Caestecker\u00a0J, Love\u00a0SB, Reilly\u00a0G, Watson\u00a0P, Sanders\u00a0S et\u00a0al (2018) Esomeprazole and aspirin in Barrett\u2019s oesophagus (AspECT): a\u00a0randomised factorial trial. Lancet 392:400\u2013408","journal-title":"Lancet"},{"key":"890_CR15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1053\/j.gastro.2017.07.049","volume":"154","author":"CP Gyawali","year":"2018","unstructured":"Gyawali\u00a0CP, Fass\u00a0R (2018) Management of gastroesophageal reflux disease. Gastroenterology 154:302\u2013318","journal-title":"Gastroenterology"},{"key":"890_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1055\/s-0042-121021","volume":"142","author":"J Labenz","year":"2017","unstructured":"Labenz\u00a0J, Koop\u00a0H (2017) Gastro\u00f6sophageale Refluxkrankheit \u2013 was tun, wenn PPI nicht ausreichend wirksam, vertr\u00e4glich oder erw\u00fcnscht sind? Dtsch Med Wochenschr 142:356\u2013366","journal-title":"Dtsch Med Wochenschr"},{"key":"890_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00228-008-0576-5","volume":"65","author":"J Kirchheiner","year":"2009","unstructured":"Kirchheiner\u00a0J, Glatt\u00a0S, Fuhr\u00a0U, Klotz\u00a0U, Meineke\u00a0I, Seufferlein\u00a0T, Brockm\u00f6ller\u00a0J (2009) Relative potency of proton-pump inhibitors\u2014comparison of effects on intragastric pH. Eur J Clin Pharmacol 65:19\u201331","journal-title":"Eur J Clin Pharmacol"},{"key":"890_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/dote\/dow020","volume":"30","author":"DA Leiman","year":"2017","unstructured":"Leiman\u00a0DA, Riff\u00a0BP, Morgan\u00a0S et al (2017) Alginate therapy is effective treatment for GERD symptoms: a\u00a0systematic review and meta-analysis. Dis Esophagus 30:1\u20139","journal-title":"Dis Esophagus"},{"key":"890_CR19","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa1811424","volume":"381","author":"SJ Spechler","year":"2019","unstructured":"Spechler\u00a0SJ, Hunter\u00a0JG, Jones\u00a0KM, Lee\u00a0R, Smith\u00a0BR, Mashimo\u00a0H et\u00a0al (2019) Randomized trial of medical versus surgical treatment for refractory heartburn. N\u00a0Engl J Med 381:1513\u20131523","journal-title":"N Engl J Med"},{"key":"890_CR20","first-page":"477","volume":"113","author":"J M\u00f6ssner","year":"2016","unstructured":"M\u00f6ssner\u00a0J (2016) The indications, apllications, and risks of proton pump inhibitors. Dtsch Arztebl Int 113:477\u2013483","journal-title":"Dtsch Arztebl Int"},{"key":"890_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1053\/j.gastro.2019.07.039","volume":"157","author":"DA Corley","year":"2019","unstructured":"Corley\u00a0DA (2019) Safety and complications of long-term proton pump inhibitor therapy: getting closer to the truth. Gastroenterology 157:604\u2013607","journal-title":"Gastroenterology"},{"key":"890_CR22","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/apt.13194","volume":"41","author":"SE Attwood","year":"2015","unstructured":"Attwood\u00a0SE, Ell\u00a0C, Galmiche\u00a0JP, Fiocca\u00a0R, Hatlebakk\u00a0JG, Hasselgren\u00a0B, L\u00e5ngstr\u00f6m\u00a0G et al (2015) Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther 41:1162\u20131174","journal-title":"Aliment Pharmacol Ther"},{"key":"890_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","volume":"157","author":"P Moayyedi","year":"2019","unstructured":"Moayyedi\u00a0P, Eikelboom\u00a0JW, Bosch\u00a0J, Connolly\u00a0SJ, Dyal\u00a0L, Shestakovska\u00a0O et al (2019) Safety of proton pump inhibitors based on a\u00a0large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin. Gastroenterology 157:682\u2013691","journal-title":"Gastroenterology"},{"key":"890_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5414\/VDX01033","volume":"37","author":"A Wannhoff","year":"2019","unstructured":"Wannhoff\u00a0A, Caca\u00a0K (2019) Endoskopische Therapieverfahren bei gastro\u00f6sophagealer Refluxkrankheit. Verdauungskrankheiten 37:1\u20137","journal-title":"Verdauungskrankheiten"},{"key":"890_CR25","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41395-018-0115-7","volume":"113","author":"R Yadlapati","year":"2018","unstructured":"Yadlapati\u00a0R, Hungness\u00a0ES, Pandolfino\u00a0JE (2018) Complications of antireflux surgery. Am J Gastroenterol 113:1137\u20131147","journal-title":"Am J Gastroenterol"},{"key":"890_CR26","doi-asserted-by":"publisher","first-page":"CD003243","DOI":"10.1002\/14651858.CD003243.pub3","volume":"11","author":"SK Garg","year":"2015","unstructured":"Garg\u00a0SK, Gurusamy\u00a0KS (2015) Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev 11:CD3243. https:\/\/doi.org\/10.1002\/14651858.CD003243.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"890_CR27","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1007\/s00464-016-5370-3","volume":"31","author":"D Skubleny","year":"2017","unstructured":"Skubleny\u00a0D, Switzer\u00a0NJ, Dang\u00a0J, Gill\u00a0RS, Shi\u00a0X, de Gara\u00a0C et al (2017) LINX\u00ae magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a\u00a0systematic review and meta-analysis. Surg Endosc 31:3078\u20133084","journal-title":"Surg Endosc"},{"key":"890_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.21037\/aoe.2018.10.03","volume":"1","author":"A Nieponice","year":"2018","unstructured":"Nieponice\u00a0A, Ramirez\u00a0M, Badaloni\u00a0A, Renda\u00a0P, Lovera\u00a0R, Ruurda\u00a0JP et\u00a0al (2018) Electrical neuromodulation oft he lower esophageal sphincter fort he treatment of gastroesophageal reflux disease. Ann. Esophagus 1:18\u201324","journal-title":"Esophagus"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-020-00890-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-020-00890-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-020-00890-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T13:27:58Z","timestamp":1608038878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-020-00890-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["890"],"URL":"https:\/\/doi.org\/10.1007\/s00108-020-00890-1","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,28]]},"assertion":[{"value":"28 October 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>J.\u00a0Labenz<\/b>: Finanzielle Interessen: Forschungs-Grant f\u00fcr eine wissenschaftliche Studie: Reckitt Benckiser, Forschungsunterst\u00fctzung klinischer Studien: EndoStim. \u2013 Vortragshonorar, Erstattung von Spesen: EndoStim, Falk Foundation, Reckitt Benckiser, Torax Medical. \u2013 Beratungshonorar: EndoStim, MSD, Reckitt Benckiser. \u2013 Gesellschafter der Firma medocs GmbH (Entwicklung von Software), gesch\u00e4ftsf\u00fchrender Gesellschafter LaMed GmbH. Nichtfinanzielle Interessen: Direktor Innere Medizin und Medizinischer Direktor, Diakonie Klinikum Jung-Stilling Krankenhaus | Mitgliedschaften: Bundesverband Gastroenterologie Deutschland (BVGD; Vorsitzender), Bundesverband Deutscher Internisten (BDI; Vorsitzender Sektion Gastroenterologie), Arbeitsgemeinschaft Leitender Gastroenterologischer Krankenhaus\u00e4rzte (ALGK; Vorstand), Deutsche Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS; Beirat, Kongresspr\u00e4sident 2015), Kongresspr\u00e4sident Viszeralmedizin NRW 2018, Rheinisch-Westf\u00e4lische Gesellschaft f\u00fcr Innere Medizin (RWGIM; Vorsitzender 2019).<b> D.-P.\u00a0Borkenstein<\/b>: Finanzielle Interessen: Pr\u00fcfarzthonorar der Firma EndoStim (Registerstudie). \u2013 Honorar f\u00fcr Vortr\u00e4ge im Rahmen von Workshops der Firma EndoStim. Nichtfinanzielle Interessen: Sektionsleiterin Allgemeine Innere Medizin, Diakonie Klinikum Jung-Stilling Krankenhaus, Siegen, Leitung Gastrointestinale Funktionsdiagnostik, Diakonie Klinikum Jung-Stilling Krankenhaus, Siegen | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Innere Medizin (DGIM), DGVS. <b>M.\u00a0M\u00fcller<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Oberarzt Innere Medizin\/Gastroenterologie, Diakonie Klinikum Jung-Stilling, Siegen | Mitgliedschaft: DGVS. <b>G.\u00a0Labenz<\/b>: Finanzielle Interessen: Pr\u00fcfarzthonorare: EndoStim, Reckitt Benckiser. \u2013 Referentenhonorar: EndoStim (Workshops), Reckitt Benckiser (Vortrag bei Kongress-Symposium). \u2013 Patente, Gesch\u00e4ftsanteile, Aktien o.\u202f\u00c4. an einer im Medizinbereich aktiven Firma: Gesellschafterin der medocs GmbH, gesch\u00e4ftsf\u00fchrende Gesellschafterin, LaMed E&C GmbH. Nichtfinanzielle Interessen: Selbstst\u00e4ndig in Privatpraxis, angestellt in Teilzeit in haus\u00e4rztlicher Praxis | Mitgliedschaften: DGIM, Deutsche Gesellschaft f\u00fcr Ern\u00e4hrungsmedizin (DGEM), DGVS, BDI.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}